Does the Presence of Diabetes Mellitus Make a Difference in Pharmacological Stress Echocardiography Outcome Results?

@inproceedings{Andova2018DoesTP,
  title={Does the Presence of Diabetes Mellitus Make a Difference in Pharmacological Stress Echocardiography Outcome Results?},
  author={Valentina Andova and Ljubica Georgievska-Ismail and Elizabeta Srbinovska and Biljana Janeska},
  booktitle={Open access Macedonian journal of medical sciences},
  year={2018}
}
BACKGROUND Coronary artery disease (CAD) is the leading cause of mortality and morbidity in patients with diabetes (DM). AIM The aim of our study was to analyse the ability of pharmacological SE to risk stratify patients with DM using qualitative and quantitative assessment of LV function. METHODS We prospectively assessed 105 consecutive patients (58.7 ± 9.5 y, 39 male) with known or suspected CAD who underwent dipyridamole or dobutamine SE. RESULTS Change of systolic LV function at… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 42 REFERENCES

Two-Dimensional Speckle-Tracking during Dobutamine Stress Echocardiography in the Detection of Myocardial Ischemia in Patients with Suspected Coronary Artery Disease.

  • Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
  • 2016
VIEW 1 EXCERPT